Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

BRIEF-Amoeba Informs On The Status Of The Applications For In The United States And Canada

Published 2019-02-01, 11:47 a/m
© Reuters.  BRIEF-Amoeba Informs On The Status Of The Applications For In The United States And Canada

Feb 1 (Reuters) - AMOEBA SA AMEBA.PA :

* INFORMS ON THE STATUS OF THE APPLICATIONS FOR REGISTRATION OF ITS BIOCIDAL PRODUCT IN THE UNITED STATES AND CANADA

* COMPANY BELIEVES THAT U.S. GOVERNMENT SHUTDOWN COULD HAVE AN IMPACT ON THE EPA'S DECISION DATE, SCHEDULED FOR THE FIRST QUARTER OF 2019.

* HAS SUBMITTED TO THE PEST MANAGEMENT REGULATORY AGENCY (PMRA) APPLICATION TO REGISTER TH ACTIVE SUBSTANCE AND BIOCIDAL PRODUCT BIOMEBA FOR PURPOSE OF MARKETING

* COMPANY BELIEVES THAT THE COMMERCIALIZATION OF BIOMEBA IN CANADA COULD BE POSSIBLE AT THE FIRST QUARTER 2021

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.